Detection of mycotoxins in patients with chronic fatigue syndrome

Toxins

Volumn 5, Issue 4, 2013, Pages 605-617

  Brewer, Joseph H ^a   Thrasher, Jack D ^b   Straus, David C ^c   Madison, Roberta A ^d   Hooper, Dennis ^e  

^a ST LUKE S HOSPITAL   (United States)

^b Texas Tech University Health Sciences Center ^*

^c TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^d CALIFORNIA STATE UNIVERSITY   (United States)

^e RealTime Laboratories Inc   (United States)

Author keywords

Chronic fatigue syndrome; Mold exposure; Mycotoxin; Stachybotrys

Indexed keywords

AFLATOXIN; MACROCYCLIC TRICHOTHECENE; MYCOTOXIN; OCHRATOXIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC FATIGUE SYNDROME; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LABORATORY TEST; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; MOULD; NONHUMAN; POPULATION EXPOSURE; PREVALENCE; TOXIN ANALYSIS; URINALYSIS;

EID: 84876161285     PISSN: 20726651     EISSN: None     Source Type: Journal    
DOI: 10.3390/toxins5040605     Document Type: Article

References (56)

1. Klimas, N.G.; Broderick, G.; Fletcher, M.A. Biomarkers for chronic fatigue. Brain Behav. Immun. 2012, 26, 1202-1210. doi: 10.1016/j.bbi.2012.06.006.
2. Komaroff, A.L. Is human herpesvirus-6 a trigger for chronic fatigue syndrome? J. Clin. Virol. 2006, 37, S39-S45.
3. Asch, E.S.; Bujak, D.I.; Weiss, M.; Peterson, M.G.E.; Weinstein, A. Lyme disease: An infectious and postinfectious syndrome. J. Rheumatol. 1994, 21, 454-461.
4. Fikuda, K.; Strauss, S.E.; Hickie, I.; Sharpe, M.C.; Dobbins, J.G.; Komaroff, A. The chronic fatigue syndrome: A comprehensive approach to its definition and study. Ann. Intern. Med. 1994, 121, 953-959.
5. Thrasher, J.D.; Crawley, S. The biocontaminants and complexity of damp indoor spaces: more than what meets the eyes. Toxicol. Ind. Health 2009, 25, 583-615.
6. Täubel, M.; Sulyok, M.; Vishwanath, V.; Bloom, E.; Turunen, M.; Järvi, K.; Kauhanen, E.; Krska, R.; Hyvärinen, A.; Larsson, L.; Nevalainen, A. Co-occurrence of toxic bacterial and fungal secondary metabolites in moisture-damaged indoor environments. Indoor Air 2011. doi:10.1111/j.1600-0668.2011.00721.x.
7. Brasel, D.; Douglas, R.; Wilson, S.C.; Straus, D.C. Detection of airborne Stachybotrys chartarum macrocyclic trichothecene mycotoxins on particulates smaller than conidia. Appl. Environ. Microbiol. 2005, 71, 112-114.
8. Gottschalk, C.; Bauer, J.; Meyer, K. Detection of Satratoxins G and H in indoor air from a water-damaged building. Mycopathologia 2008, 166, 103-107.
9. Smoragiewicz, W.; Cossette, B.; Boutard, A.; Krzystyniak, K. Trichothecene mycotoxins in the dust of ventilation systems of office buildings. Int. Arch. Occup. Environ. Health 1993, 65, 113-117.
10. Polizzi, V.; Delmulle, B.; Adams, A.; Moretti, A.; Susca, A.; Picco, A.M.; Rosseel, Y.; Kindt, R.; Van Bocxlaer, J.; De Kimpe, N.; Van Peteghem, C.; De Saeger, S. JEM spotlight: fungi, mycotoxins and microbial volatile organic compounds in mouldy interiors of water-damaged buildings. J. Environ. Monit. 2009, 11, 1849-1858.
11. Bloom, E.; Nyman, E.; Must, A.; Pehrson, C.; Larsson, L. Molds and mycotoxins in indoor environments - a survey in water-damaged buildings. J. Occup. Environ. Hyg. 2009, 6, 671-678.
12. Tuomi, T.; Reijula, K.; Johnsson, T.; Hemminki, K.; Hintikka, E.L.; Lindroos, O.; Kalso, S.; Koukila-Kähkölä, P.; Mussalo-Rauhamaa, H.; Haahtela, T. Mycotoxins in crude building materials from water-damaged buildings. Appl. Environ. Microbiol. 2000, 66, 1899-1904.
13. Engelhart, S.; Loock, A.; Skutlarek, D.; Sagunski, H.; Lommel, A.; Färber, H.; Exner, M. Occurrence of toxigenic Aspergillus versicolor isolates and sterigmatocystin in carpet dust from damp indoor environments. Appl. Environ. Microbiol.2002, 68, 3886-3890.
14. Peitzsch, M.; Sulyok, M.; Täubel, M.; Vishwanath, V.; Krop, E.; Borràs-Santos, A.; Hyvärinen, A.; Nevalainen, A.; Krska, R.; Larsson, L. Microbial secondary metabolites in school buildings inspected for moisture damage in Finland, the Netherlands and Spain. J. Environ. Monit. 2012, 14, 2044-2053.
15. Polizzi, V.; Adams, A.; Malysheva, S.V.; De Saeger, S.; Van Peteghem, C.; Moretti, A.; Picco, A.M.; De Kimpe, N. Identification of volatile markers for indoor fungal growth and chemotaxonomic classification of Aspergillus species. Fungal Biol. 2012, 116, 941-953.
16. Polizzi, V.; Adams, A.; Picco, A.M.; Adriaens, E.; Lenoir, J.; Van Peteghem, C.; De Saeger, S.; De Kimpe, N. Influence of environmental conditions on production of volatiles by Trichoderma atroviride in relation with sick building syndrome. Build. Environ. 2011, 46, 945-954.
17. Leema, G.; Kaliamurthy, J.; Geraldine, P.; Thomas, P.A. Keratitis due to Aspergillus flavus: Clinical profile, molecular identification of fungal strains and detection of aflatoxin production. Mol. Vis. 2010, 16, 843-854.
18. Matsumura, M.; Mori, T. Detection of aflatoxins in autopsied materials from a patient infected with Aspergillus flavus. Jpn. J. Med. Mycol. 1998, 39, 167-171.
19. Lewis, R.E.; Wiederhold, N.P.; Lionakis, M.S.; Prince, R.A.; Kontoyiannis, D.P. Frequency and species distribution of gliotoxin-producing Aspergillus isolates recovered from patients at a tertiary-care cancer center. J. Clin. Microbiol. 2005, 63, 6120-6122.
20. Lewis, R.E.; Wiederhold, N.P.; Chi, J.; Han, X.Y.; Komanduri, K.V.; Kontoyiannis, D.P.; Prince, R.A. Detection of gliotoxin in experimental and human aspergillosis. Infect. Immun. 2005, 73, 635-637.
21. Hooper, D.G.; Bolton, V.E.; Guilford, F.T.; Straus, D.C. Mycotoxin detection in human samples from patients exposed to environmental molds. Int. J. Mol. Sci. 2009, 10, 1465-1475.
22. Thrasher, J.D.; Gray, M.R.; Kilburn, K.H.; Dennis, D.; Yu, A. A water-damaged home and health of occupants: A case study. J. Environ. Public Health 2012, Article ID 312836, doi:10.1155/2012/312836.
23. Lieberman, S.M.; Jacobs, J.B.; Lebowitz, R.A.; Fitzgerald, M.B.; Crawford, J.; Feigenbaum, B.A. Measurement of mycotoxins in patients with chronic rhinosinusitis. Otolaryg. Head Neck Surg. 2011, 145, 327-329.
24. Rea, W.J.; Didriksen, N.; Simon, T.R.; Pan, Y.; Fenyves, E.J.; Griffiths, G. Effects of toxic exposure to molds and mycotoxins in building-related illnesses. Arch. Environ. Heath 2003, 58, 399-405.
25. Rea, W.; Pan, Y.; Griffiths, B. The treatment of patients with mycotoxin-induced disease. Toxicol. Indust. Health 2009, 25, 711-714.
26. Curtis, L.; Leiberman, A.; Stark, M.; Rea, W.; Vetter, M. Adverse Health Effects of Indoor Molds. J. Aust. Coll. Nutr. Env. Med. 2004, 23, 3-8.
27. Campbell, A.; Thrasher, J.D.; Gray, M.R.; Vojdani, A. Mold and mycotoxins: Effects on the neurological and immune systems in humans. Adv. Appl. Microbiol. 2004, 55, 375-398.
28. Chester, A.C.; Levine, P. Concurrent sick building syndrome and chronic fatigue syndrome: Epidemic neuromyasthenia revisited. Clin. Infect. Dis. 1994, 18, S43-S48.
29. Gray, M.R.; Thrasher, J.D.; Crago, R.; Madison, R.A.; Arnold, L.; Campbell, A.W.; Vojdani, A. Mixed mold mycotoxicosis: Immunological changes in humans following exposure to water-damaged buildings. Arch. Environ. Health 2003, 58, 410-420.
30. Edmondson, D.A.; Nordness, M.E.; Zacharison, M.C.; Kurup, V.P.; Fink, J.N. Allergy and "toxic mold syndrome." Ann. Allergy Asthma Immunol. 2005, 94, 234-239.
31. Vesper, S.; McKinstry, C.; Cox, D.; Dewalt, G. Correlation between ERMI values and other moisture and mold assessments of homes in the American healthy home survey. J. Urban. Health 2009, 86, 850-860.
32. Wong, R.; Lopaschuk, G.; Zhu, G.; Walker, D.; Catellier, D.; Burton, D.; Teo, K.; Collins-Nakai, R.; Montague, T. Skeletal muscle metabolism in the chronic fatigue syndrome. In vivo assessment by 31P nuclear magnetic resonance spectroscopy. Chest 1992, 102, 716-722.
33. Lane, R.J.; Barrett, M.; Taylor, D.; Kemp, G.J.; Lodi, R. Heterogeneity in chronic fatigue syndrome: evidence from magnetic resonance spectroscopy of muscle. Neuromuscul. Disord. 1998, 8, 204-209.
34. Booth, N.E.; Myhill, S.; McLaren-Howard, J. Mitochondrial dysfunction and the pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Int. J. Clin. Exp. Med. 2012, 5, 208-220.
35. Gorny, R.L. Filamentous microorganisms and their fragments in indoor air-A review. Ann. Agric. Environ. Med. 2004, 11, 185-197.
36. Cho, S.-H.; Seo, S.-C.; Schmechel, D.; Grinshpun, A.G.; Reponen, T. Aerodynamic characteristics and respiratory deposition of fungal fragments. Atmos. Environ. 2005, 39, 5454-5465.
37. Reponen, T.; Seo, S.-C.; Grimsley, F.; Lee, T.; Crawford, C.; Grinshpun, S.A. Fungal fragments in moldy houses: A field study in homes in New Orleans and Southern Ohio. Atmos. Environ. 2007, 41, 8140-8149.
38. Ammann, H.M. Mycotoxins in indoor environments. Mycotoxin Res. 2005, 21, 157-163.
39. Straus, D.C. Molds, mycotoxins and sick building syndrome. Toxicol. Indust. Health 2009, 25, 617-635.
40. Straus, D.C. The possible role of fungal contaminants in sick building syndrome. Front. Biosci. 2011, E3, 562-580.
41. Mitochondrial Disease Foundation. Mitochondrial Disease in Adults. Available online: http://www.umdf.org/site/pp.aspx?c=8qKOJ0MvF7LUG&b=7934631 (accessed on 15 November 2012).
42. 1 carcinogenesis. Cancer Res. 1982, 42, 1866-1880.
43. Shamsuddin, A.M.; Harris, C.C.; Hinzman, M.J. Localization of aflatoxin B2-nucleic acid adducts in mitochondria and nuclei. Carcinogenesis 1987, 8, 109-114.
44. Rainbow, L.; Maxwell, S.M.; Hendrickes, R.G. Ultrastructural changes in murine lymphocytes induced by aflatoxin B1. Mycopathologia 1994, 125, 33-39.
45. Yang, X.J.; Lu, H.Y.; Li, Z.Y.; Bian, Q.; Qiu, L.L.; Li, Z.; Liu, Q.; Li, J.; Wang, X.; Wang, S.L. Cytochrome P450 2A13 mediates aflatoxin B1-induced cytotoxicity and apoptosis in human bronchial epithelial cells. Toxicology 2012, 28, 138-148.
46. Rocha, A.; Ansari, K.; Doohan, F.M. Effects of trichothecene mycotoxins on eurkaryotic cells: a review. Food Addit. Contam. 2005, 22, 369-378.
47. Chaudhari, M.; Jayaraj, R.; Bhaskar, A.S.; Lakshmana, P.V. Oxidative stress induction by T-2 toxin causes DNA damage and triggers apoptosis via caspase pathway in human cervical cancer cells. Toxicology 2009, 262, 153-161.
48. Bin-Ulmer, M.A.; McLaughlin, J.E.; Basu, D.; McCormick, S.; Turner, N.E. Trichothecene mycotoxins inhibit mitochondrial translation-implication for the mechanism of toxicity. Toxins (Basel) 2011, 3, 1484-1501.
49. Bouaziz, C.; Sharif el dein, O.; El Golli, E.; Abid-Essefi, S.; Brenner, C.; Lermaire, C.; Bacha, H. Different apoptic pathways induced by zeralenone, T-2 toxin and ochratoxin A in human hepatoma cells. Toxicology 2006, 254, 19-28.
50. Bouaziz, C.; Martel, C.; Sharaf el dein, O.; Abid-Essefi, S.; Brenner, C.; Lemaire, C.; Bacha, H. Fusarial toxin-induced toxicity in culture cells and in isolated mitochondria involve PTPC-dependent activation of the mitochondrial pathway of apoptosis. Toxicology 2009, 110, 363-375.
51. Kamp, H.G.; Eisenbrand, G.; Schlatter, J.; Worth, K.; Janzowski, C. Ochratoxin, A: Induction of oxidative DNA damage, cytotoxicity and apoptosis in mammalian cell lines and primary cells. Toxicology 2005, 206, 413-425.
52. Wei, Y.H.; Lu, C.Y.; Lin, T.N.; Wei, R.D. Effect of ochratoxin A on rat liver mitochondrial respiration and oxidative phosphorylation. Toxicology 1985, 36, 119-130.
53. Prabu, P.C.; Dwivedi, P.; Sharma, A.K. Toxicopathological studies on the effects of aflatoxin B(1), ochratoxin A, and the interaction in New Zealand white rabbits. Exper. Toxicol. Pathol. 2013, 65, 277-286. doi: 10.1016/j.etp.2011.09.003. Epub 2011 Oct 19.
54. Arbillaga, L.; Azqueta, A.; Ezpeleta, O.; López de Cerain, A. Oxidative damage induced by ochratoxin A in HK-2 human kidney cells: evidence of the relationship with cytotoxicity. Mutagenesis 2006, 22, 35-42.
55. Kilburn, K.H. Neurobehavioral and pulmonary impairment in 105 adults with indoor exposure to indoor molds compared to 100 exposed to chemicals. Toxicol. Indust. Health 2009, 25, 681-692.
56. Empting, L.D. Neurologic and neuropsychiatric syndrome features of mold and mycotoxin exposure. Toxicol. Indust. Health 2009, 25, 571-581.